Bone and joint complications related to Gaucher disease.

被引:52
作者
Pastores G.M. [1 ]
Patel M.J. [1 ]
Firooznia H. [1 ]
机构
[1] New York University School of Medicine, Neurogenetics Laboratory, RR, 400 East 34th Street, New York
关键词
Osteonecrosis; Enzyme Replacement Therapy; Gauche Disease; Skeletal Complication; Orthopedic Intervention;
D O I
10.1007/s11926-000-0059-x
中图分类号
学科分类号
摘要
There is a broad spectrum of Gaucher disease-related skeletal complications, ranging from asymptomatic osteopenia to osteonecrosis (of the shoulders and hips) with secondary degenerative joint disease. Characterization of the pattern and severity of bone involvement in the individual patient requires the application of conventional and advanced radiographic techniques. The introduction of enzyme replacement therapy (ERT) for this inborn error of glycosphingolipid metabolism has focused great interest in determining the nature and extent of the bone responses with this mode of treatment. The multifactorial etiology of the bone complications necessitates a multifaceted approach, combining pharmacologic strategies with physical therapy and orthopedic intervention. As bone disease can lead to chronic pain and debility with a resultant adverse impact on quality of life, it is important that patients be monitored closely and that early intervention with ERT prior to established bone disease (infarction and fibrosis) be considered.
引用
收藏
页码:175 / 180
页数:5
相关论文
共 87 条
[1]  
Pastores GM(1995)Skeletal complications of Gaucher disease: pathophysiology, evaluation and treatment Semin Hematol 32 20-27
[2]  
Einhorn TA(1989)Activator protein deficient Gaucher’s Klinische Wochenschrift. 67 999-1003
[3]  
Christomanou H(1996)The natural history of osteonecrosis of the femoral head in children and adolescents who have Gaucher disease J Bone Joint Surg 78A 14-19
[4]  
Chabas A(1997)Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis Clin Orthopaed & Related Research 334 43-56
[5]  
Pampols T(1997)Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy Br J Haemat 96 470-476
[6]  
Guardiola A(1985)Skeletal complications of Gaucher disease Medicine 64 310-322
[7]  
Katz K(1997)Pro-inflammatory cytokines and the pathogenesis of Gaucher’s disease: increased release of interleukin-6 and interleukin-10 QJM 90 19-25
[8]  
Horev G(1997)Gaucher disease Curr Opinion Hemat 4 19-23
[9]  
Grunebaum M(1980)Coexistence of IgA myeloma and Gaucher’s disease Arch Med 140 1115-1116
[10]  
Glueck CJ(1995)Malignant epithelioid hemangioendothelioma of the tibia associated with a bone infarct in a patient who had Gaucher disease: a case report J Bone Joint Surg Am Vol 77 777-781